The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results

Competing interests

Financial Disclosures: Dr. Khanani reports personal fees from AbbVie, grants and personal fees from Adverum Biotechnologies, personal fees from AGTC, personal fees from Alimera Sciences, personal fees from Allergan, grants and personal fees from Apellis Pharmaceuticals, personal fees from Arrowhead Pharmaceuticals, personal fees and other from Aviceda Therapeutics, personal fees from Bausch & Lomb, personal fees from Broadwing Bio, personal fees from Clearside Biomedical, grants and personal fees from 4D Molecular Therapeutics, grants and personal fees from Eyepoint Pharmaceuticals, personal fees from Fronterra Therapeutics, grants and personal fees from Gemini Pharmaceuticals, grants and personal fees from Genentech, grants and personal fees from Gyroscope Therapeutics, grants and personal fees from Iveric Bio, grants and personal fees from Janssen Pharmaceuticals, personal fees from Kato Pharmaceuticals, grants and personal fees from Kodiak Sciences, grants and personal fees from Ocular Therapeutix, grants and personal fees from Oculis, grants and personal fees from Ocuterra, grants and personal fees from Opthea, grants and personal fees from Oxurion, grants and personal fees from Novartis, personal fees from Perfuse, personal fees and other from PolyPhotonix, personal fees from Ray Therapeutics, grants, personal fees and other from Recens Medical, personal fees from Regeneron Pharmaceuticals, grants and personal fees from Regenxbio, grants and personal fees from Roche, personal fees from Stealth Biotherapeutics, personal fees from Thea Pharma, grants and personal fees from Unity Biotechnology, personal fees from Vanotech, personal fee and other from Vial, grants from Annexon Biosciences, grants from Neurotech, grants from NGM Biopharmaceuticals, other from PolyPhotonix outside the submitted work. Mr. Aziz reports other from Regenxbio, outside the submitted work; paid summer internship. Ms. Khan has nothing to disclose. Mr. Gupta has nothing to disclose. Mr. Mojumder has nothing to disclose. Dr. Saulebayeva reports personal fees from AbbVie, outside the submitted work. Dr. Abbey reports personal fees from Genentech, outside the submitted work. Dr. Almeida reports personal fees and other from Acerlyrin, personal fees from Alcon, personal tees and other from Alimera sciences, personal fees and other from Abbvie, personal fees from Bausch and Lomb, personal fees from Bayer, personal fees and other from Boehringer Ingelheim, personal fees, non-financial support and other from Citrus Therapeutics, personal fees, non-financial support and other from Clinical Trials Network, personal fees and other from Eyepoint Pharmaceuticals, personal fees and other from Genentech, personal fees and other from Gyroscope therapeutics, personal fees and other from Novartis, personal fees from Ocugen, personal fees and other from Opthea, personal fees from Regeneron, personal fees and other from Regenxbio, personal fees and other from Roche, personal fees and other from Samsara Vision, personal fees from Spherix Consulting Group, outside the submitted work. Dr. Avery reports personal fees from Alcon, personal fees from Alimera, personal fees from Amgen, personal fees from Asclepix, personal fees from Aviceda, personal fees from Bausch & Lomb, personal fees from Clearside, personal fees from Eyepoint, personal fees from Genentech, personal fees from Glaukos, personal fees from Imprimis, personal fees from Ingenia, personal fees from Kriya, personal fees from Novartis, personal fees from Ocular Therapeutix, personal fees from Ocuterra, personal fees from Oyster point, personal fees from Prevent AI, personal fees from Regenxbio, personal fees from Revana, personal fees from Santen, personal fees from Tenpoint, personal fees from Vial, personal fees from Cardinal, personal fees from Coherus, personal fees from 4D Molecular Therapeutics, outside the submitted work. Dr. Banda reports personal fees from Genentech, outside the submitted work. Dr. Barakat reports personal fees from Alcon, personal fees from Allegro, personal fees from Allergan, personal fees from Alimera, personal fees from Bausch & Lomb, grants and personal fees from Clearside Biomedical, grants and personal fees from EyePoint Pharmaceuticals, grants and personal fees from Kodiak Sciences, grants and personal fees from Genentech, grants and personal fees from Novartis, other from NeuBase, personal fees from Ocular Therapeutix, grants and other from Oxurion, grants and personal fees from RegenxBio, grants and personal fees from Adverum Biotechnologies, personal fees from Regeneron, grants and personal fees from Graybug, personal fees from Palatin Technologies, personal fees from AbbVie Inc, grants from Annexon Biosciences, personal fees from Apellis, personal fees from Arctic Vision, personal fees from Biogen, personal fees from Coherus Biosciences, grants from Gemini Therapeutics, grants from Gyroscope Therapeutics, grants from Oxular, grants from Oculis, grants and personal fees from Opthea, personal fees from Outlook Therapeutics, grants from ReNeuron, other from RevOpsis Therapeutics, grants from Ribomic, personal fees from Roche, grants from Stealth Biotherapeutics, grants from Unity Biotechnology, outside the submitted work. Dr, Bhandari reports personal fees from Novartis, Apellis Pharmaceuticals, Regeneron, Vial, grants from Kodiak Biosciences, Regeneron, Regenxbio, Ionis, patents for a glaucoma drainage device and RO-101 bispecific antibody, stock and leadership in the Springfield Clinic and Revopsis Therapeutics, outside the submitted work. Dr. Chang has nothing to disclose. Dr. Haug has nothing to disclose. Dr. London reports grants and personal fees from Genentech, personal fees from Alimera, grants and personal fees from Opthea, grants and personal fees from Annexon, grants and personal fees from Apellis, personal fees from Bayer, grants and personal fees from Gyroscope, personal fees from Ionis, grants and personal fees from Kodiak, grants and personal fees from NGM Biopharmaceuticals, grants and personal fees from Oxurion, grants and personal fees from Regenxbio, personal fees from Regeneron, personal fees from Sandoz, from null, from null, outside the submitted work. Dr. Mein has nothing to disclose. Dr. Sheth reports grants and personal fees from Genentech, grants and personal fees from Alimera, grants and personal fees from Novartis, grants and personal fees from Iveric Bio, grants and personal fees from Regeneron, grants from Gyroscope, grants from RegenXBio, grants from Chengdu Kanghong, grants from NGM Biopharmaceuticals, grants from SamChungDang, grants from Sandoz, grants from Alkahest, grants and personal fees from Apellis, grants from EyePoint, grants from Oxurion, grants from 4D Molecular Therapeutics, grants from Ashvattha Therapeutics, grants from NGM Biopharmaceuticals, grants from Olix Pharmaceuticals, grants from Janssen, from OcuTerra, outside the submitted work. Dr. Wolfe reports grants and personal fees from Allergan, grants and personal fees from Genentech, grants from Novartis, grants and personal fees from Regeneron, outside the submitted work. Dr. Singer reports personal fees from Prime Medica, Regeneron, Guidepoint, Aerie Pharmaceuticals, Novartis, Genentech, Allergan, grants from Novartis, Genentech, Allergan, Optos, Allegro, Ionis, Aerpio, Apellis, Graybug Vision, Kodiak Biosciences, and financial interest in Avecida, Nanoscope and Inflammasome, outside the submitted work. Dr. Danzig reports grants, personal fees and other from Genentech/Roche, grants and personal fees from Regeneron/Bayer, grants and personal fees from Adverum, grants from Kodiak, grants from Unity, grants and personal fees from RegenxBio, personal fees from Allergan, grants, personal fees and other from Novartis, grants and personal fees from IvericBio, grants from Alexion, grants from Gyroscope, outside the submitted work.

留言 (0)

沒有登入
gif